ArticleDiscover oncology2026

Anti-CD38 targeted carfilzomib-loaded hybrid nanocomposites for multiple myeloma therapy: cytotoxicity and biodistribution.

Deepak Mishra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.